Group A:Qidi Tangshen Formulation

2 trials

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

Conditions

diabetic nephropathy

Phase 1

Effects of Qidi Tangshen Formulation in treating DKD patients with albuminuria

RecruitingITMCTR2100004852

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicinediabetic nephropathy

Start: 2021-05-10Updated: 2023-02-20

Effects of Qidi Tangshen Formulation in treating DKD patients with albuminuria

RecruitingChiCTR2100046403

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicinediabetic nephropathy

Start: 2021-05-10Updated: 2022-01-04